XTX Ventures
Venture Capital
Active
London, United Kingdom
46
13M
34
9
0.26
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4 participants. Despite the XTX Ventures, startups are often financed by Vasudev Bailey, Sutter Health, SMDV. The meaningful sponsors for the fund in investment in the same round are Seraph Group, NTT Venture Capital, Mayo Clinic.
The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually.
The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight REalyse, Eko. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Software.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 623K — 6M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 46
- Lead investments
- 9
- Follow on index
- 0.26
- Investments by industry
- Artificial Intelligence (23)
- Software (19)
- Machine Learning (16)
- Health Care (14)
- Medical (7) Show 60 more
- Investments by region
-
- United States (15)
- United Kingdom (21)
- Hungary (3)
- Israel (2)
- Spain (1) Show 1 more
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.67
- Avg. company exit year
- 16
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lucida Medical | 26 Feb 2021 | Biotechnology, Software, Health Care | Seed | Cambridgeshire, Cambridge, United Kingdom | |
| Qureight | 15 Apr 2024 | Health Care | Early Stage Venture | 9M | Cambridgeshire, Cambridge, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.